72 related articles for article (PubMed ID: 35913431)
1. Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
Greene SK; Rett MD; Vellozzi C; Li L; Kulldorff M; Marcy SM; Daley MF; Belongia EA; Baxter R; Fireman BH; Jackson ML; Omer SB; Nordin JD; Jin R; Weintraub ES; Vijayadeva V; Lee GM
PLoS One; 2013; 8(6):e67185. PubMed ID: 23840621
[TBL] [Abstract][Full Text] [Related]
2. Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
Lehmann HC; Oberle D; Keller-Stanislawski B; Rieck T; Streit R
Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318764
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010.
Burwen DR; Sandhu SK; MaCurdy TE; Kelman JA; Gibbs JM; Garcia B; Markatou M; Forshee RA; Izurieta HS; Ball R;
Am J Public Health; 2012 Oct; 102(10):1921-7. PubMed ID: 22970693
[TBL] [Abstract][Full Text] [Related]
4. Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.
Deeks SL; Lim GH; Simpson MA; Rosella L; Mackie CO; Achonu C; Crowcroft NS
BMC Public Health; 2011 May; 11():329. PubMed ID: 21586163
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome and influenza vaccines: current evidence.
Sanz Fadrique R; Martín Arias L; Molina-Guarneros JA; Jimeno Bulnes N; García Ortega P
Rev Esp Quimioter; 2019 Aug; 32(4):288-295. PubMed ID: 31232571
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis.
Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
J Neurol; 2024 Mar; 271(3):1063-1071. PubMed ID: 38233678
[TBL] [Abstract][Full Text] [Related]
7. Vaccine patterns among patients diagnosed with Guillain-Barré Syndrome and matched counterparts in a Medicare supplemental population, 2000-2020.
Eiffert SR; Stürmer T; Thorpe CT; Traub R; Raman SR; Pate V; Kinlaw AC
Vaccine; 2023 Sep; 41(39):5763-5768. PubMed ID: 37573203
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned from annotation of VAERS reports on adverse events following influenza vaccination and related to Guillain-Barré syndrome.
Sankaranarayanapillai M; Wang S; Ji H; Song HY; Tao C
BMC Med Inform Decis Mak; 2024 Jan; 23(Suppl 4):298. PubMed ID: 38183034
[TBL] [Abstract][Full Text] [Related]
9. Influenza Vaccination and Risk of Ischemic Stroke: A Population-Based Case-Control Study.
Rodríguez-Martín S; Barreira-Hernández D; Gil M; García-Lledó A; Izquierdo-Esteban L; De Abajo F
Neurology; 2022 Nov; 99(19):e2149-e2160. PubMed ID: 36240087
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data.
Atzenhoffer M; Auffret M; Pegat A; Masmoudi K; Khouri C; Bertin B; Vial T
Clin Drug Investig; 2022 Jul; 42(7):581-592. PubMed ID: 35676452
[TBL] [Abstract][Full Text] [Related]
11. A report of a probable case of familial Guillain Barre syndrome.
Barzegar M; Rouhi AH; Farhoudi M; Sardashti S
Ann Indian Acad Neurol; 2012 Oct; 15(4):299-302. PubMed ID: 23349598
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.
Schonberger LB; Bregman DJ; Sullivan-Bolyai JZ; Keenlyside RA; Ziegler DW; Retailliau HF; Eddins DL; Bryan JA
Am J Epidemiol; 1979 Aug; 110(2):105-23. PubMed ID: 463869
[TBL] [Abstract][Full Text] [Related]
13. The role of vaccines in the COVID-19 pandemic: what have we learned?
Krammer F
Semin Immunopathol; 2024 Jan; 45(4-6):451-468. PubMed ID: 37436465
[TBL] [Abstract][Full Text] [Related]
14. Triggers of Guillain-Barré Syndrome:
Finsterer J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430700
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome following influenza vaccination: A 15-year nationwide population-based case-control study.
Levison LS; Thomsen RW; Andersen H
Eur J Neurol; 2022 Nov; 29(11):3389-3394. PubMed ID: 35913431
[TBL] [Abstract][Full Text] [Related]
16. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
[TBL] [Abstract][Full Text] [Related]
17. Vaccines and the risk of Guillain-Barré syndrome.
Chen Y; Zhang J; Chu X; Xu Y; Ma F
Eur J Epidemiol; 2020 Apr; 35(4):363-370. PubMed ID: 31858323
[TBL] [Abstract][Full Text] [Related]
18. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B;
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
Vellozzi C; Iqbal S; Broder K
Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
